BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37803527)

  • 1. Natural history of blood pressure in sickle cell disease pregnancy.
    Early ML; Luo A; Solow M; Matusiak K; Eke AC; Shehata N; August P; Kuo KHM; Lanzkron S; Malinowski AK; Pecker LH
    Br J Haematol; 2024 Feb; 204(2):658-667. PubMed ID: 37803527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood pressure thresholds for the diagnosis of hypertensive disorders of pregnancy in sickle cell disease.
    Early ML; Raja M; Luo A; Solow M; Matusiak K; Eke AC; Shehata N; Kuo KHM; Lanzkron S; Malinowski AK; Pecker LH
    Br J Haematol; 2024 Mar; 204(3):1039-1046. PubMed ID: 38093478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxyurea (hydroxycarbamide) for sickle cell disease.
    Nevitt SJ; Jones AP; Howard J
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002202. PubMed ID: 28426137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxyurea (hydroxycarbamide) for sickle cell disease.
    Rankine-Mullings AE; Nevitt SJ
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD002202. PubMed ID: 36047926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC.
    Drawz P; Ayyappan S; Nouraie M; Saraf S; Gordeuk V; Hostetter T; Gladwin MT; Little J
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):207-15. PubMed ID: 26672090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pattern of sickle cell disease in pregnancy in Lagos, Nigeria.
    Ogedengbe OK; Akinyanju O
    West Afr J Med; 1993; 12(2):96-100. PubMed ID: 8398940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Children with HbSβ
    Day ME; Rodeghier M; DeBaun MR
    Pediatr Blood Cancer; 2018 Nov; 65(11):e27352. PubMed ID: 30094930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative blood transfusions for sickle cell disease.
    Estcourt LJ; Kimber C; Trivella M; Doree C; Hopewell S
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD003149. PubMed ID: 32614473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between hydroxycarbamide exposure and neurocognitive function in adolescents with sickle cell disease.
    Partanen M; Kang G; Wang WC; Krull K; King AA; Schreiber JE; Porter JS; Hodges J; Hankins JS; Jacola LM
    Br J Haematol; 2020 Jun; 189(6):1192-1203. PubMed ID: 32103506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurocognitive functioning in preschool children with sickle cell disease.
    Heitzer AM; Cohen DL; Okhomina VI; Trpchevska A; Potter B; Longoria J; Porter JS; Estepp JH; King A; Henley M; Kang G; Hankins JS
    Pediatr Blood Cancer; 2022 Mar; 69(3):e29531. PubMed ID: 34971013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total Serum Magnesium Levels and Calcium-To-Magnesium Ratio in Sickle Cell Disease.
    Antwi-Boasiako C; Kusi-Mensah YA; Hayfron-Benjamin C; Aryee R; Dankwah GB; Kwawukume LA; Darkwa EO
    Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31470666
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence and correlates of growth failure in young African patients with sickle cell disease.
    Alexandre-Heymann L; Dubert M; Diallo DA; Diop S; Tolo A; Belinga S; Sanogo I; Diagne I; Wamba G; Boidy K; Ly ID; Kamara I; Traore Y; Offredo L; Jouven X; Ranque B
    Br J Haematol; 2019 Jan; 184(2):253-262. PubMed ID: 30467843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative studies of live neonates in maternal sickle cell haemoglobinopathy in Ghana.
    Addai FK; Wilson JB; Quashie FJ
    Trop Geogr Med; 1992 Oct; 44(4):312-6. PubMed ID: 1295139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel permeability characteristics of red blood cells from sickle cell patients heterozygous for HbS and HbC (HbSC genotype).
    Dalibalta S; Ellory JC; Browning JA; Wilkins RJ; Rees DC; Gibson JS
    Blood Cells Mol Dis; 2010 Jun; 45(1):46-52. PubMed ID: 20227897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic analysis in placentas from sickle cell disease patients reveals a hypermethylation profile.
    Gil GP; Ananina G; Maschietto M; Lima SCS; da Silva Costa SM; Baptista LC; Ito MT; Costa FF; Costa ML; de Melo MB
    PLoS One; 2022; 17(9):e0274762. PubMed ID: 36129958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demographics and outcomes of hemoglobin genotype in hospitalized patients with COVID-19 and sickle cell disease in the United States.
    Ilerhunmwuwa NP; Inyang L; Wasifuddin M; Aiwuyo H; Tahir M; Hakobyan N; Ankah P; Torere BE; Amaechi UM; Rayapureddy AK; Wang JC
    Eur J Haematol; 2023 Oct; 111(4):611-619. PubMed ID: 37477175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative blood transfusions for sickle cell disease.
    Estcourt LJ; Fortin PM; Trivella M; Hopewell S
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD003149. PubMed ID: 27049331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormality of erythrocyte membrane n-3 long chain polyunsaturated fatty acids in sickle cell haemoglobin C (HbSC) disease is not as remarkable as in sickle cell anaemia (HbSS).
    Ren H; Ghebremeskel K; Okpala I; Ugochukwu CC; Crawford M; Ibegbulam O
    Prostaglandins Leukot Essent Fatty Acids; 2006 Jan; 74(1):1-6. PubMed ID: 16314081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic kidney disease and albuminuria in children with sickle cell disease.
    McPherson Yee M; Jabbar SF; Osunkwo I; Clement L; Lane PA; Eckman JR; Guasch A
    Clin J Am Soc Nephrol; 2011 Nov; 6(11):2628-33. PubMed ID: 21940843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Most adults with severe HbSC disease are not treated with hydroxyurea.
    Ghunney WK; Asare EV; Ayete-Nyampong JB; Oppong SA; Rodeghier M; DeBaun MR; Olayemi E
    Blood Adv; 2023 Jul; 7(13):3312-3319. PubMed ID: 36799926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.